1. Home
  2. KIND vs IKT Comparison

KIND vs IKT Comparison

Compare KIND & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KIND
  • IKT
  • Stock Information
  • Founded
  • KIND 2011
  • IKT 2008
  • Country
  • KIND United States
  • IKT United States
  • Employees
  • KIND N/A
  • IKT N/A
  • Industry
  • KIND Computer Software: Programming Data Processing
  • IKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • KIND Technology
  • IKT Health Care
  • Exchange
  • KIND Nasdaq
  • IKT Nasdaq
  • Market Cap
  • KIND 608.3M
  • IKT 131.6M
  • IPO Year
  • KIND N/A
  • IKT 2020
  • Fundamental
  • Price
  • KIND $1.62
  • IKT $1.89
  • Analyst Decision
  • KIND Buy
  • IKT Buy
  • Analyst Count
  • KIND 4
  • IKT 2
  • Target Price
  • KIND $2.56
  • IKT $8.00
  • AVG Volume (30 Days)
  • KIND 2.1M
  • IKT 521.7K
  • Earning Date
  • KIND 08-06-2025
  • IKT 08-13-2025
  • Dividend Yield
  • KIND N/A
  • IKT N/A
  • EPS Growth
  • KIND N/A
  • IKT N/A
  • EPS
  • KIND N/A
  • IKT N/A
  • Revenue
  • KIND $248,306,000.00
  • IKT N/A
  • Revenue This Year
  • KIND $1.77
  • IKT N/A
  • Revenue Next Year
  • KIND $10.72
  • IKT N/A
  • P/E Ratio
  • KIND N/A
  • IKT N/A
  • Revenue Growth
  • KIND 12.01
  • IKT N/A
  • 52 Week Low
  • KIND $1.32
  • IKT $1.12
  • 52 Week High
  • KIND $3.00
  • IKT $4.20
  • Technical
  • Relative Strength Index (RSI)
  • KIND 55.06
  • IKT 51.83
  • Support Level
  • KIND $1.55
  • IKT $1.56
  • Resistance Level
  • KIND $1.66
  • IKT $2.04
  • Average True Range (ATR)
  • KIND 0.07
  • IKT 0.15
  • MACD
  • KIND 0.00
  • IKT 0.02
  • Stochastic Oscillator
  • KIND 68.75
  • IKT 69.47

About KIND Nextdoor Holdings Inc.

Nextdoor Holdings Inc is the platform to connect to the neighborhoods. The purpose is to cultivate a kinder world where everyone has a neighborhood. Neighbors around the world turn to Nextdoor daily to receive trusted information, give and get help, get things done, and build real-world connections with nearby neighbors, businesses, and public services. It offers a comprehensive suite of advertising solutions designed to deliver exceptional value for businesses of all size.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: